Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | ALUR | Common Stock | 1.66M | Aug 1, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | ALUR | Stock Option (Right to Buy) | Aug 1, 2023 | Common Stock | 48.9K | $1.13 | Direct | F1 | ||||||
holding | ALUR | Stock Option (Right to Buy) | Aug 1, 2023 | Common Stock | 122K | $1.13 | Direct | F1 | ||||||
holding | ALUR | Stock Option (Right to Buy) | Aug 1, 2023 | Common Stock | 14.7K | $1.17 | Direct | F2 | ||||||
holding | ALUR | Contingency Shares | Aug 1, 2023 | Common Stock | 483K | Direct | F3, F4 |
Id | Content |
---|---|
F1 | This options is fully vested. |
F2 | This option shall vest and become exercisable in monthly installments over a period of 48 months from January 1, 2020, subject to the Reporting Person's continued service on each such vesting date. |
F3 | Subject to the terms and conditions pursuant to that certain Business Combination Agreement ("BCA") dated as of February 9, 2023, as amended on May 2, 2023, by and among Compute Health Acquisition Corp., Compute Health Corp., Compute Health LLC, the Issuer (fka Allurion Technologies Holdings, Inc.), and Allurion Technologies, Inc. ("Private Allurion"), the contingent right to receive shares of Common Stock ("Contingency Shares"), was issued as follows: one-half of the Contingency Shares, in the aggregate, if, from the period beginning on the date on which the Issuer's registration statement on Form S-1 with respect to the resale of any Common Stock issued pursuant to the PIPE Financing is declared effective by the SEC until the date which is five calendar years after the Closing Date ("Earnout Period"), |
F4 | (Continued from footnote 3) the VWAP is greater than or equal to $15.00 over any 20 trading days within any consecutive 30 trading day period ("First Share Target"); and one-half of the Contingency Shares, in the aggregate, if, during the Earnout Period, the VWAP is greater than or equal to $20.00 over any 20 trading days within any consecutive 30 trading day period ("Second Share Target"). |
Exhibit 24 - Power of Attorney